Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Chang

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Orphanet Journal of Rare Diseases|May 6, 2008
Adaptive design methods in clinical trials - a reviewShein-Chung Chow, Mark Chang
Journal of Biopharmaceutical Statistics|November 21, 2007
Analysis strategies for adaptive designs with multiple endpointsMark Chang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics|May 27, 2015
Biomarker informed add-arm design for unimodal responseJing Wang, Mark Chang, Sandeep Menon
Oncotarget|July 3, 2024
Addendum: Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case seriesMark Chang, Wolfram Samlowski, Raul Meoz
Oncotarget|July 7, 2023
Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case seriesMark Chang, Wolfram Samlowski, Raul Meoz
Current Opinion in Hematology|October 4, 2018
Restoring antiviral immunity with adoptive transfer of ex-vivo generated T cellsEdoardo Migliori, Mark Chang, Pawel Muranski
Journal of Biopharmaceutical Statistics|June 7, 2014
An Adaptive Staggered Dose Design for a Normal EndpointJoseph Wu, Sandeep Menon, Mark Chang
Statistics in Medicine|May 19, 2005
Statistical inference for cancer trials with treatment switchingJun Shao, Mark Chang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics|May 27, 2006
Adaptive design in clinical research: issues, opportunities, and recommendationsMark Chang, Shein-Chung Chow, Annpey Pong
Journal of Biopharmaceutical Statistics|March 14, 2017
Unified additional requirement in consideration of regional approval for multiregional clinical trialsZhaoyang Teng, Yeh-Fong Chen, Mark Chang
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Orphanet Journal of Rare Diseases|May 6, 2008
Adaptive design methods in clinical trials - a reviewShein-Chung Chow, Mark Chang
Journal of Biopharmaceutical Statistics|November 21, 2007
Analysis strategies for adaptive designs with multiple endpointsMark Chang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics|May 27, 2015
Biomarker informed add-arm design for unimodal responseJing Wang, Mark Chang, Sandeep Menon
Oncotarget|July 3, 2024
Addendum: Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case seriesMark Chang, Wolfram Samlowski, Raul Meoz
Oncotarget|July 7, 2023
Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case seriesMark Chang, Wolfram Samlowski, Raul Meoz
Current Opinion in Hematology|October 4, 2018
Restoring antiviral immunity with adoptive transfer of ex-vivo generated T cellsEdoardo Migliori, Mark Chang, Pawel Muranski
Journal of Biopharmaceutical Statistics|June 7, 2014
An Adaptive Staggered Dose Design for a Normal EndpointJoseph Wu, Sandeep Menon, Mark Chang
Statistics in Medicine|May 19, 2005
Statistical inference for cancer trials with treatment switchingJun Shao, Mark Chang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics|May 27, 2006
Adaptive design in clinical research: issues, opportunities, and recommendationsMark Chang, Shein-Chung Chow, Annpey Pong
Journal of Biopharmaceutical Statistics|March 14, 2017
Unified additional requirement in consideration of regional approval for multiregional clinical trialsZhaoyang Teng, Yeh-Fong Chen, Mark Chang
Pageof 6